Orionis Biosciences collaborates with Genentech to discover molecular glues
Sep. 21, 2023
Orionis Biosciences BV has established a multiyear collaboration with Genentech Inc., a member of the Roche Group, to discover novel small-molecule molecular glues for targets in major disease areas, including oncology and neurodegeneration.